ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $147,000 | +0.7% | 44,560 | -7.6% | 0.01% | -12.5% |
| Q1 2019 | $146,000 | +9.0% | 48,207 | -2.0% | 0.01% | -11.1% |
| Q4 2018 | $134,000 | -58.5% | 49,186 | -51.0% | 0.01% | -71.0% |
| Q2 2017 | $323,000 | +2836.4% | 100,330 | +2408.2% | 0.03% | +3000.0% |
| Q1 2017 | $11,000 | -94.3% | 4,000 | -91.6% | 0.00% | -96.8% |
| Q3 2013 | $194,000 | – | 47,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |